Global Travel Vaccines Market Professional Survey Report 2019

Vaccines are a combination of killed microorganisms, living attenuated organisms or living fully virulent organisms that are monitored for artificially increasing or creating immunity for any particular disease. The branch of medicine that deals with the prevention and management of health problems of international travellers is called Emporiatrics. Travel vaccine is the first step towards smart and healthy travel. Nowadays along with the passport, travel vaccine shots are a must have before a person embarks on international travel. Travel vaccines provide immunisation by reducing the risk of getting sick while travelling abroad. Tourists traveling to South America and central countries of Africa should get vaccinated for Yellow Fever. Likewise, different countries have different diseases existing or prevailing within the region. Travel vaccines are recommended by health organisations especially to tourists who travel to developing or endemic countries. DUKORAL is an example of a travel vaccine that protects tourists from Diarrhea and Cholera. These are the common diseases caused by intake of contaminated food and water while travelling. Travel vaccine shot recommendations vary from person to person depending on gender, age and medical history of the tourist.
As the world continues to move toward globalization, the international travels is expected to keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan.
The Americas was the highest revenue contributing region in the market during 2017 and is expected to continue to lead the market in the coming years. The US was one of the highest revenue contributor in the region, capturing a significant portion of the global market. The increasing demand for vaccines that cater to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will aid in the growth of this market in the region.

The global Travel Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Travel Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Travel Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Travel Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Travel Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Sanofi
GlaxoSmithKline
Merck
AstraZeneca
Abbott
Roche
Takeda Pharmaceutical
Valeant Pharmaceuticals
SK Chemicals
Hualan Biological Engineering
Serum Institute of India

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Meningococcal Vaccines
Hepatitis B Vaccines
Hepatitis A Vaccines
Others

Segment by Application
Domestic Travel
Outbound Travel